A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Key Takeaways The S&P 500 added 0.5% on Wednesday, July 2, 2025, reaching a record-high close for the second time this week, as the U.S. announced a trade deal with Vietnam.Coinbase shares rose. The ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

Shionogi will pay BioVersys $6.3 million for developing BV500, BioVersys's drug candidate for non-tuberculous mycobacteria.

Sabic to close UK cracker, plastics recycler Novoloop raises funds, Kymera strikes molecular glue deal, and more ...

Relative to before the pandemic, the number of vaccinated participants fell 10% among children and 4% in adults in pandemic ...

New research shows that people with worse symptoms of lactose intolerance tended to report more frequent nightmares.

Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joins Bob Sirott to talk ...

An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination ...

Tariffs, uncertainty, and inflation crimped stocks in first half of 2025 after AI frenzy and strong earnings sent Nasdaq up 18% in 2024. Bet on companies Trump favors.